Code
OSC00151W
$240USD
ID Tag
Sh162-280609-WS
Immunogen
A synthetic peptide from the internal region of human CTRP5 (Complement C1q tumor necrosis factor-related protein 5, C1QTNF5) conjugated to an immunogenic carrier protein was used as the immunogen.
Accession
Also known
Complement C1q tumor necrosis factor-related protein 5, C1QTNF5
Target
Defects in C1QTNF5 are a cause of late-onset retinal degeneration (LORD). LORD is an autosomal dominant disorder characterized by onset in the fifth to sixth decade with night blindness and punctate yellow-white deposits in the retinal fundus, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy.
Subcellular location: Secreted
Storage
Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date
12 months after reconstitution
Shipping
This item will be shipped to you at ambient temperature in a lyophilised form.
References
1. Taylor T.D, et al. Nature 440:497-500(2006)
2. Zhang Z, et al. Protein Sci. 13:2819-2824(2004)
3. Hayward C, et al. Hum. Mol. Genet. 12:2657-2667(2003)
4. Clark H.F, et al. Genome Res. 13:2265-2270(2003)
Limitation
For research use only
Code
OSC00151W
$240USD
Unit size
100 µl
Conjugate
Unconjugated antibody
Host
Sheep
Purity
Whole serum
Clonality
Polyclonal
Isotype
Polyclonal, whole serum
Applications
IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications.
Specificity
Specific for CTRP5.
Spcs X-react.
Human, rat, mouse. Other species not yet tested.
Format
Lyophilised
Reconstitution
Reconstitute in 100 µl of sterile water. Centrifuge to remove any insoluble material.